1972
DOI: 10.1001/archpsyc.1972.01750300086016
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Treatment of Tardive Dyskinesia

Search citation statements

Order By: Relevance

Paper Sections

Select...
27
0
0
0

Citation Types

0
1
0
0

Year Published

1973
1973
2017
2017

Publication Types

Select...
18
8
1

Relationship

0
27

Authors

Journals

citations

Cited by 27 publications

(1 citation statement)
references

References 20 publications

0
1
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Multiple observational and comparison trials have shown it to be helpful in patients at dosages of 100 mg/d. 4,[114][115][116][117] However, use is limited because of significant side effects, short half-life, and drug-drug interactions. LIMITATIONS OF TETRABENAZINE.…”
Section: New Pharmacotherapeutic Agents For Td
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Multiple observational and comparison trials have shown it to be helpful in patients at dosages of 100 mg/d. 4,[114][115][116][117] However, use is limited because of significant side effects, short half-life, and drug-drug interactions. LIMITATIONS OF TETRABENAZINE.…”
Section: New Pharmacotherapeutic Agents For Td
mentioning
confidence: 99%